Hematology, Hematopoietic Transplantation and Cell Therapy
Complejo Hospitalario de Toledo
Toledo, EspañaPublications in collaboration with researchers from Complejo Hospitalario de Toledo (6)
2022
-
Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers
Cancer Epidemiology, Vol. 78
-
Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease
Blood Advances, Vol. 6, Núm. 17, pp. 5244-5255
2020
-
Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic
Pediatric Blood and Cancer
-
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment
Frontiers in Pediatrics, Vol. 8
2019
-
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma
Blood, Vol. 134, Núm. 16, pp. 1337-1345
2010
-
Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma
Blood, Vol. 116, Núm. 8